The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study
- PMID: 29506503
- PMCID: PMC5838864
- DOI: 10.1186/s12882-018-0851-3
The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study
Abstract
Background: Klotho, a protein linked to aging, has emerged as a pivotal player in mineral bone metabolism and might explain the relationship between chronic kidney disease (CKD) and cardiovascular disease (CVD). The present study aimed to investigate the association between serum klotho and cardiac parameters from a large-scale Korean CKD cohort.
Methods: We analyzed 2101 participants from KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease (KNOW-CKD) cohort who had been measured for serum klotho levels. Left ventricular hypertrophy evaluated by left ventricular mass index (LVMI) and arterial stiffness measured by brachial-to-ankle pulse wave velocity (baPWV) were explored as cardiovascular parameters.
Results: Patients were 53.6 ± 12.2 years old and 61.1% were male. The mean estimated glomerular filtration rate (eGFR) was 53.0 ± 30.7 mL/min/1.73m2. The median serum klotho level was 536 (interquartile range [IQR]: 420-667) pg/mL. Advanced CKD stages were associated with lower serum klotho levels (P < 0.001, P for linear trend < 0.001). Ascending quartiles of klotho were significantly associated with decreased LMVI (P < 0.001, P for linear trend< 0.001). A multivariable linear regression model showed serum klotho had a significant inverse association with LVMI (β - 0.04; 95% CI [confidence interval] -0.004, - 0.00007; P = 0.041). However, there was no significant association between serum klotho and baPWV after adjustment (β 0.003; 95% CI -0.04, 0.05; P = 0.876).
Trial registration: This trial was registered on ClinicalTrials.gov on 28 June 2012 ( NCT01630486 ).
Conclusions: Serum klotho was an independent biomarker of LVMI, but not arterial stiffness.
Keywords: Chronic kidney disease; Left ventricular hypertrophy; Left ventricular mass index; Pulse wave velocity; Serum klotho; Soluble klotho.
Conflict of interest statement
Ethics approval and consent to participate
The study protocol was approved by the ethical committee of each participating clinical center, including the Institutional Review Boards of Seoul National University Hospital, Severance Hospital, Kangbuk Samsung Medical Center, Seoul St. Mary’s Hospital, Gil Hospital, Eulji General Hospital, Chonnam National University Hospital, and Busan Paik Hospital. All participating patients provided written informed consent. The study protocol was in accordance with the principles of the Declaration of Helsinki.
Consent for publication
Not applicable.
Competing interest
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



Similar articles
-
[Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].Ter Arkh. 2015;87(6):10-16. doi: 10.17116/terarkh201587610-16. Ter Arkh. 2015. PMID: 26281189 Russian.
-
Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study.BMC Nephrol. 2019 Apr 3;20(1):119. doi: 10.1186/s12882-019-1297-y. BMC Nephrol. 2019. PMID: 30943913 Free PMC article.
-
The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.Pediatr Nephrol. 2018 Jan;33(1):147-157. doi: 10.1007/s00467-017-3766-5. Epub 2017 Aug 9. Pediatr Nephrol. 2018. PMID: 28795324 Free PMC article.
-
Arterial Stiffness and Decline in Kidney Function.Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2190-7. doi: 10.2215/CJN.03000315. Epub 2015 Nov 12. Clin J Am Soc Nephrol. 2015. PMID: 26563380 Free PMC article. Review.
-
Lower circulating soluble Klotho level is associated with increased risk of all-cause mortality in chronic kidney disease patients: a systematic review and meta-analysis.Int Urol Nephrol. 2020 Aug;52(8):1543-1550. doi: 10.1007/s11255-020-02510-1. Epub 2020 May 27. Int Urol Nephrol. 2020. PMID: 32462356
Cited by
-
The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease.Int J Gen Med. 2021 Mar 15;14:857-866. doi: 10.2147/IJGM.S299197. eCollection 2021. Int J Gen Med. 2021. PMID: 33758533 Free PMC article.
-
The association between klotho and kidney and cardiovascular outcomes: a comprehensive systematic review and meta-analysis.Clin Kidney J. 2024 Aug 23;17(9):sfae255. doi: 10.1093/ckj/sfae255. eCollection 2024 Sep. Clin Kidney J. 2024. PMID: 39281418 Free PMC article. Review.
-
Association between soluble α-klotho and mortality risk in middle-aged and older adults.Front Endocrinol (Lausanne). 2023 Aug 24;14:1246590. doi: 10.3389/fendo.2023.1246590. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37693344 Free PMC article.
-
Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function.Kidney Int. 2023 May;103(5):949-961. doi: 10.1016/j.kint.2023.01.008. Epub 2023 Feb 2. Kidney Int. 2023. PMID: 36738890 Free PMC article.
-
Left ventricular myocardial mass index associated with cardiovascular and renal prognosis in IgA nephropathy.BMC Nephrol. 2022 Aug 16;23(1):285. doi: 10.1186/s12882-022-02909-1. BMC Nephrol. 2022. PMID: 35974314 Free PMC article.
References
-
- Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. 2001;12:1079–1084. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous